Form 8-K - Current report:
SEC Accession No. 0000950170-24-107259
Filing Date
2024-09-17
Accepted
2024-09-17 16:05:40
Documents
11
Period of Report
2024-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20240913.htm   iXBRL 8-K 37868
  Complete submission text file 0000950170-24-107259.txt   147277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20240913.xsd EX-101.SCH 23892
13 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20240913_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241304260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)